A humble background was never a dampener for Mr. Pandey who was all set to make it big owing to his earnest efforts and unwavering determination. Under his quintessential leadership, Bravo Pharma has been consistently charting newer trajectories of success and is looking forward to exploring avenues and business interests in Central Asia, Europe, USA, Africa, South East Asia and Australia.
EARLY LEANINGS
A bright student, Mr. Pandey obtained his preliminary education from Bihar and obtained a graduation degree in Commerce from the University of Delhi in the year 1999. He further completed his Post Graduation in Management from the Department of Economics & Commerce, the University of Delhi in 2001. A multilinguist, he has learnt five languages namely English, Hindi, German, Russian, and Sanskrit. He has also obtained the Degree of Doctor of Philosophy in International Relations (Honoris Causa) from Keisie International University.
Mr. Pandey started his career as the International Marketing Head with ABB – a Swiss mega engineering company. Here, he drove business growth through identification and penetration of new market segments for attainment of targets with a view to optimize revenue. At ABB, he worked for cancer research, R&D manufacturing of drugs and their distribution in 8 countries globally. He also oversaw the execution of 132 KVA Transmission line from Kanchan Kalalaipur Northern Grid, Nepal under Nepal Electricity Authority. The Government of Nepal and Intertech-Alstom consortium under the Danida Private Sector Development Programme (the PSD Programme) jointly executed the project. He has also successfully executed the single-phase transformer for the railway’s transmission projects in Southern Colombo regions.
He established an EPC company in 2006 and personally monitored and executed around 17 projects. As he puts it, “I have executed the APDRP Project of Government of India; Ministry of Energy, under the Rural Electrification programme with the value of around USD 5.7 million.”
LAYING THE CORNERSTONE OF EXCELLENCE
Having acquired a rich experience owing to his tenure at multinational companies like ABB, Mr. Pandey decided to launch his healthcare venture. As he puts it, “In 2008, the company Bravo Pharma was established and since then I am working to expand the healthcare business globally. Bravo Pharma is a group of companies focused on drug development; R&D in oncology and liver diseases; manufacturing, marketing and sales of medical products; medical tourism; telemedicine and diagnostics. Currently, Bravo Pharma has activities spread across Asia, Africa, Middle East and Europe. We have total 262 employees and 27 research scientists working in the manufacturing facility and R&D Centre.”
COLLABORATING FOR CREATING BREAKTHROUGH INVENTIONS
Under his able leadership, Bravo Pharma has been working closely with the John’s Hopkins Cancer Hospital, Baltimore, USA. In addition, Harlev Hospitals, Denmark, have financed the firm’s on-going cancer research programme for the development of the Biomarkers for pancreatic cancer. Mr. Pandey has also established Joint Cooperation with National Enterprise Corporation (NEC), Ministry of Defence, Uganda, and Ministry of Police Reform Uganda, for the development of e-healthcare platform for central Africa.
The firm has been working in coordination on “HEPAMUT” R&D project with CCCR, Competent Centre of Cancer Research Tallinn, Estonia and Cambridge, UK. It is jointly working on the new drug discovery project and for the Oncology Advance Lab pre-clinical trials, with University College of London, London. It also holds the credit of setting up the first Referral Laboratory specialised in Oncological research and clinical trial in the Republic Oncology Hospital, Uzbekistan on BOT basis.
Mr. Pandey aims to serve humanity by providing quality pharmaceuticals across never nook and corner of the globe. Sharing his plans with regard to the expansion of the firm, he elaborates, “The next strategic aim of Bravo Pharma is to expand its activities in Europe. The two target countries selected are UK and France. In United Kingdom, Bravo Pharma has already established relations with University College London (UCL).” He further adds, “The plan is to establish an R&D Company in the neighbourhood of UCL in order to be in close proximity to the university facilities and highly qualified personnel. The focus of this company at London will be R&D in cancer research, patenting and trademark issues.”
MAKING A POSITIVE IMPACT ON THE WORLD
Extremely passionate about giving back to society, Mr. Pandey launched BRAVO Foundation to provide aid to the needy sections of society all across the globe. The best aspect of Bravo Foundation is that its welfare activities are not limited to a specific region and it endeavours to reach out to the needy in every corner of the globe. Sharing some of welfare activities personally undertaken by him, Mr. Pandey elaborates, “I monitored and run a charity programme for Cancer Treatment, free medical camp in Asia, Central Asia, and Africa for poor patients. In the year 2015-2017, total 1364 kids were given financial help for cancer treatment from my personal funds.” He adds, “I personally, monitored and financed the free training programme of doctors and professors from various hospitals in Asia and Europe.”
The Foundation has launched several initiatives for employment of youth and women, disseminating education and providing healthcare facilities across Bihar. Bravo foundation also launched the Bravo Scholarship Program in 2016, for the Students of INHA University, Tashkent; Tallinn Technical University, Tallinn, Estonia; and Tartu University, Estonia; and MGCUB Mahatma Gandhi Central University, Motihari East Champaran Bihar, India.
For his determination to provide affordable healthcare to all, he has received numerous awards and accolades such as Excellence Award, Business Tycoon and Inspiring Social Activist 2019 at House of Commons, UK, to name a few.
